Quick Takeaways
- Ho Chi Sing filed SCHEDULE 13D/A for CASI Pharmaceuticals, Inc. Ordinary Shares, par value US$0.0001 per share (CASI).
- Disclosed ownership: 4.8%.
- Date of event: 30 Sep 2025.
Quoteable Key Fact
"Ho Chi Sing disclosed 4.8% ownership in CASI Pharmaceuticals, Inc. Ordinary Shares, par value US$0.0001 per share (CASI) on 30 Sep 2025."
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
See Original Filing| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| IDG-Accel China Growth Fund III L.P. | 4.5% | 915,850 | 855,222 | 60,628 | /s/ Chi Sing Ho on behalf of IDG-Accel China Growth Fund GP III Associates Ltd., ultimate General Partner of IDG-Accel China Growth Fund III L.P. | Chi Sing Ho / Authorized Signatory | 0001508829 |
| IDG-Accel China III Investors L.P. | 4.5% | 915,850 | 60,628 | 855,222 | /s/ Chi Sing Ho on behalf of IDG-Accel China Growth Fund GP III Associates Ltd., General Partner of IDG-Accel China III Investors L.P. | Chi Sing Ho / Authorized Signatory | 0001550193 |
| IDG-Accel China Growth Fund III Associates L.P. | 4.5% | 915,850 | 855,222 | 60,628 | /s/ Chi Sing Ho on behalf of IDG-Accel China Growth Fund GP III Associates Ltd., General Partner of IDG-Accel China Growth Fund III Associates L.P. | Chi Sing Ho / Authorized Signatory | 0001550192 |
| IDG-Accel China Growth Fund GP III Associates Ltd. | 4.5% | 915,850 | 915,850 | 0 | /s/ Chi Sing Ho | Chi Sing Ho / Authorized Signatory | 0001564281 |
| Ho Chi Sing | 4.5% | 915,850 | 0 | 915,850 | /s/ Ho Chi Sing | Ho Chi Sing | 0001545806 |
| Zhou Quan | 4.8% | 992,638 | 76,788 | 915,850 | /s/ Quan Zhou | Quan Zhou | 0001491503 |